Sébastien Renouf

Sébastien Renouf is the Chief Pharmaceutical Officer at PathoQuest. Sébastien has over 13 years of experience in the pharmaceutical industry, including previous positions as Chief Pharmaceutical Officer (DGD) / Head of Quality at CELLforCURE and Regulatory Strategy Project Leader at LFB Biotech. Sébastien has also served as a Consultant for IDM Pharma.

Sébastien has a wealth of experience in quality and regulatory affairs, having overseen harmonization of quality systems between French and US facilities at IDM Pharma, as well as obtaining a positive opinion from the FDA for Pre Approval Inspection. Sébastien has also been responsible for EMEA MAA, MHRA, FDA and Afssaps CTA at various companies.

Sébastien’s experience extends to the development of human proteins collected from milk of transgenic animals and the development of an autologous immunotherapy based on modified haematopoietic cells.

Sébastien Renouf is a pharmacist who earned their Doctor of Pharmacy (Pharm.D.) from Paris-Sud University (Paris XI) and their M2 in Biotechnologies thérapeutiques from Pierre and Marie Curie University.

Sébastien Renouf reports to Jean-François Brepson, President & CEO. They are on a team with Pascale Beurdeley Fehlbaum - Chief Scientific Officer, Michael Mellor-Clark - Chief Commercial Officer, and Eric Cazergue - CFO.